Is pretransplant platelet transfusion refractoriness associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies?
Our findings suggest that PTR before HPCT identifies patients at higher risk of early clinical rather than immunologic complications.
iNOS/NO participates in the mechanisms of Abeta-induced neurotoxicity and may play an important role in the pathogenesis of AD.